Ramaswamy Govindan, MD, and Jaafar Bennouna, MD: Results From the AvaALL Trial

Posted: Monday, June 5, 2017

Ramaswamy Govindan, MD, of Washington University, and Jaafar Bennouna, MD, of the University of Nantes Institut de Cancerologie de l’Ouest, discuss efficacy and safety results in a phase III study of standard of care with or without continuous bevacizumab treatment beyond progression in patients with advanced non–small cell lung cancer progressing after first-line bevacizumab and chemotherapy.